Qiagen NV's Therascreen EGFR RGQ PCR Kit gained FDA approval alongside Boehringer Ingelheim GmbH's lung cancer drug Gilotrif (afatinib), putting another notch in the win column for the growing companion diagnostics space, though there are still challenges to overcome before the use of companion diagnostics becomes routine in the marketplace.